(Q55052899)

16 June 2018

title

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging. (English)

1 reference

16 June 2018

1 reference

2

1 reference

16 June 2018

Lorenzo Stefano Maffioli

7

1 reference

16 June 2018

Arturo Chiti

11

1 reference

16 June 2018

Giovanna Pepe

Giovanna Pepe

10

0 references

Silvana Del Vecchio

Silvana Del Vecchio

6

0 references

Cumali Aktolun

Cumali Aktolun

3

0 references

Wim Oyen

Wim Oyen

9

0 references

author name string

Emilio Bombardieri

1

1 reference

16 June 2018

Richard P Baum

4

1 reference

16 June 2018

Angelica Bishof-Delaloye

5

1 reference

16 June 2018

Luc Mortelmans

8

1 reference

16 June 2018

Oncology Committee of the EANM

12

1 reference

16 June 2018

publication date

1 July 2010

1 reference

16 June 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

16 June 2018

volume

37

1 reference

16 June 2018

issue

7

1 reference

16 June 2018

page(s)

1441-1448

1 reference

16 June 2018

https://scigraph.springernature.com/pub.10.1007/s00259-010-1473-6

exact match

0 references

cites work

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-010-1473-6

Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide

21 January 2018

1 reference

12 December 2020

Radiological Protection in Biomedical Research. A report of Committee 3 adopted by the International Commission on Radiological Protection

1 reference

12 December 2020

Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours

1 reference

12 December 2020

Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide

1 reference

12 December 2020

Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy

1 reference

12 December 2020

Routine quality control recommendations for nuclear medicine instrumentation

1 reference

12 December 2020

Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers

1 reference

12 December 2020

SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors

1 reference

12 December 2020

Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP Publication 53. ICRP Publication 106. Approved by the Commission in October 2007

1 reference

12 December 2020

Somatostatin-receptor imaging in the localization of endocrine tumors

1 reference

12 December 2020

Radionuclide imaging of neuroendocrine tumours: biological basis and diagnostic results.

1 reference

12 December 2020

Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours

1 reference

12 December 2020

Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study

1 reference

12 December 2020

Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity?

1 reference

12 December 2020

Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors.

1 reference

12 December 2020

Indium-111–Pentetreotide Scintigraphy and Somatostatin Receptor Subtype 2 Expression: New Prognostic Factors for Malignant Well-Differentiated Endocrine Tumors

1 reference

12 December 2020

Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors

1 reference

12 December 2020

Somatostatin receptor scintigraphy in surveillance of pediatric brain malignancies.

1 reference

12 December 2020

Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas.

1 reference

12 December 2020

Radiation dose to patients from radiopharmaceuticals. A report of a Task Group of Committee 2 of the International Commission on Radiological Protection

1 reference

12 December 2020

SPECT/CT hybrid imaging with 111In‐pentetreotide in assessment of neuroendocrine tumours

1 reference

12 December 2020

Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53)

1 reference

12 December 2020

Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overview

1 reference

12 December 2020

Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan).

1 reference

12 December 2020

Somatostatin receptor imaging in intracranial tumours

1 reference

12 December 2020

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide

1 reference

12 December 2020

Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management

1 reference

12 December 2020

Somatostatin receptor imaging in patients with sarcoidosis

1 reference

12 December 2020

Somatostatin-receptor positive brain stem glioma visualized by octreoscan.

1 reference

12 December 2020

Radiolabeled peptides in diagnosis and tumor imaging: clinical overview

1 reference

12 December 2020

Comparison of MIBG and pentetreotide scintigraphy in children with neuroblastoma. Is the expression of somatostatin receptors a prognostic factor?

1 reference

12 December 2020

Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors.

1 reference

12 December 2020

Somatostatin analogue scintigraphy in carcinoid tumours

1 reference

12 December 2020

10.1007/S00259-010-1473-6

Identifiers

DOI

1 reference

16 June 2018

Dimensions Publication ID

0 references

1 reference

16 June 2018